newsfilter
← Latest News
GlobeNewswire·

CymaBay Therapeutics to Present at the SVB Securities Global Biopharma Conference

NEWARK, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high